First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent

Active, not recruiting

Phase 2/3 Results N/A

Summary of Purpose

Prospective, multi-center, randomized 1:1 single blind trial using NOVA sirolimus eluting stent versus Apollo bare metal stent conducted in approximately 15 interventional neurology centers in China. The study was sponsored by Sino Medical Sciences Technology Inc.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 October 2015.

1 Aug 2015 29 Sep 2015 1 Sep 2017 1 Sep 2017 1 Oct 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Subject)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available